TY - JOUR
T1 - Chronotype Genetic Variant in PER2 is Associated with Intrinsic Circadian Period in Humans
AU - Chang, Anne Marie
AU - Duffy, Jeanne F.
AU - Buxton, Orfeu M.
AU - Lane, Jacqueline M.
AU - Aeschbach, Daniel
AU - Anderson, Clare
AU - Bjonnes, Andrew C.
AU - Cain, Sean W.
AU - Cohen, Daniel A.
AU - Frayling, Timothy M.
AU - Gooley, Joshua J.
AU - Jones, Samuel E.
AU - Klerman, Elizabeth B.
AU - Lockley, Steven W.
AU - Munch, Mirjam
AU - Rajaratnam, Shantha M.W.
AU - Rueger, Melanie
AU - Rutter, Martin K.
AU - Santhi, Nayantara
AU - Scheuermaier, Karine
AU - Van Reen, Eliza
AU - Weedon, Michael N.
AU - Czeisler, Charles A.
AU - Scheer, Frank A.J.L.
AU - Saxena, Richa
N1 - Funding Information:
We thank the study participants; the staff of the Center for Clinical Investigation of the Brigham and Women’s Hospital, the Chronobiology Core, and the recruitment office of the Division of Sleep and Circadian Disorders, for their assistance with the in-laboratory studies. We also thank the staff of the Partners Healthcare Personalized Medicine Biobank and the Broad Institute for their work on the genetic samples. This research has also been conducted using the UK Biobank Resource under application number 6818. We would like to thank the participants and researchers from the UK Biobank who contributed or collected data. This analysis was supported by National Institutes of Health (NIH) grant R21DK089378 and by a pilot grant from the Harvard Catalyst, The Harvard Clinical and Translational Science Center (UL1 TR001102) and financial contributions from Harvard University and its affiliated academic healthcare centers to F.A.J.L.S. and R.S. Collection of DNA from study participants was supported by NIH grants F32HL078360, R01HL080978, P01AG009975, and R21DK089378. Data collection in the inpatient protocol was supported by the following grants: NIH R01AG06072, R01HL077453, P01AG009975, R21AT002571, R01HL080978, R01NS054277, R01MH45130, R01HL093279, R01HL094654, R01HL077399, and UL1 TR001102; AFOSR FA9550-06-0080; NSBRI HFP01601; and NARSAD Young Investigator Award. A-M.C. was further supported by T32HL007901, F32HL078360, and K01HL115458; E.B.K. by NIH K24HL105664, P01AG009975, R01GM105018, R01HL114088, and R21HD086392 and NSBRI HFP02802; J.M.L. by F32DK102323; K.S. by T32HL07901 and F32AG031690; F.A.J.L.S. by R01HL140574, R01HL094806, R01DK099512, R01HL118601, R01DK102696, and R01DK105072; and R.S. by R01DK107859, R01DK102696, R01DK105072, R21HL121728 and R01HL113338. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, the NIH, AFOSR, or NSBRI.
Publisher Copyright:
© 2019, The Author(s).
PY - 2019/12/1
Y1 - 2019/12/1
N2 - The PERIOD2 (PER2) gene is a core molecular component of the circadian clock and plays an important role in the generation and maintenance of daily rhythms. Rs35333999, a missense variant of PER2 common in European populations, has been shown to associate with later chronotype. Chronotype relates to the timing of biological and behavioral activities, including when we sleep, eat, and exercise, and later chronotype is associated with longer intrinsic circadian period (cycle length), a fundamental property of the circadian system. Thus, we tested whether this PER2 variant was associated with circadian period and found significant associations with longer intrinsic circadian period as measured under forced desynchrony protocols, the ‘gold standard’ for intrinsic circadian period assessment. Minor allele (T) carriers exhibited significantly longer circadian periods when determinations were based on either core body temperature or plasma melatonin measurements, as compared to non-carriers (by 12 and 11 min, respectively; accounting for ~7% of inter-individual variance). These findings provide a possible underlying biological mechanism for inter-individual differences in chronotype, and support the central role of PER2 in the human circadian timing system.
AB - The PERIOD2 (PER2) gene is a core molecular component of the circadian clock and plays an important role in the generation and maintenance of daily rhythms. Rs35333999, a missense variant of PER2 common in European populations, has been shown to associate with later chronotype. Chronotype relates to the timing of biological and behavioral activities, including when we sleep, eat, and exercise, and later chronotype is associated with longer intrinsic circadian period (cycle length), a fundamental property of the circadian system. Thus, we tested whether this PER2 variant was associated with circadian period and found significant associations with longer intrinsic circadian period as measured under forced desynchrony protocols, the ‘gold standard’ for intrinsic circadian period assessment. Minor allele (T) carriers exhibited significantly longer circadian periods when determinations were based on either core body temperature or plasma melatonin measurements, as compared to non-carriers (by 12 and 11 min, respectively; accounting for ~7% of inter-individual variance). These findings provide a possible underlying biological mechanism for inter-individual differences in chronotype, and support the central role of PER2 in the human circadian timing system.
UR - http://www.scopus.com/inward/record.url?scp=85063749094&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063749094&partnerID=8YFLogxK
U2 - 10.1038/s41598-019-41712-1
DO - 10.1038/s41598-019-41712-1
M3 - Article
C2 - 30926824
AN - SCOPUS:85063749094
SN - 2045-2322
VL - 9
JO - Scientific Reports
JF - Scientific Reports
IS - 1
M1 - 5350
ER -